George B Abercrombie - Net Worth and Insider Trading
George B Abercrombie Net Worth
The estimated net worth of George B Abercrombie is at least $4 Million dollars as of 2024-05-05. George B Abercrombie is the Sr. VP & Chief Comm. Officer of Innoviva Inc and owns about 285,479 shares of Innoviva Inc (INVA) stock worth over $4 Million. George B Abercrombie is also the Director of BioCryst Pharmaceuticals Inc and owns about 0 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $0. Details can be seen in George B Abercrombie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George B Abercrombie has not made any transactions after 2022-04-18 and currently still holds the listed stock(s).
Transaction Summary of George B Abercrombie
George B Abercrombie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George B Abercrombie owns 5 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Fresh Tracks Therapeutics Inc (FRTX) , and Innoviva Inc (INVA) among others .
Click here to see the complete history of George B Abercrombie’s form 4 insider trades.
Insider Ownership Summary of George B Abercrombie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-04-18 | director |
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | director |
| INVA | Innoviva Inc | 2018-08-21 | Sr. VP & Corp. Partnerships |
 | | 2012-08-07 | director |
| | 2010-04-05 | director |
George B Abercrombie Latest Holdings Summary
George B Abercrombie currently owns a total of 2 stocks. Among these stocks, George B Abercrombie owns 285,479 shares of Innoviva Inc (INVA) as of August 21, 2018, with a value of $4 Million and a weighting of 100%. George B Abercrombie also owns 0 shares of BioCryst Pharmaceuticals Inc (BCRX) as of April 18, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of George B Abercrombie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INVA | Innoviva Inc | 2018-08-21 | 285,479 | 15.20 | 4,339,281 |
| BCRX | BioCryst Pharmaceuticals Inc | 2022-04-18 | 0 | 4.45 | 0 |
Holding Weightings of George B Abercrombie
George B Abercrombie Form 4 Trading Tracker
According to the SEC Form 4 filings, George B Abercrombie has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the sale of 8,000 shares on August 21, 2018, which brought George B Abercrombie around $112,880.
According to the SEC Form 4 filings, George B Abercrombie has made a total of 8 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 5,000 shares on April 18, 2022, which brought George B Abercrombie around $55,200.
Insider Trading History of George B Abercrombie
- 1
George B Abercrombie Trading Performance
GuruFocus tracks the stock performance after each of George B Abercrombie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George B Abercrombie is 54.31%. GuruFocus also compares George B Abercrombie's trading performance to market benchmark return within the same time period. The performance of stocks bought by George B Abercrombie within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George B Abercrombie's insider trading performs compared to the benchmark.
Performance of George B Abercrombie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.8 | | | | | |
| Relative Return to S&P 500(%) | 21.14 | | | | | |
George B Abercrombie Ownership Network
George B Abercrombie Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
George B Abercrombie is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include director & CEO Jon P Stonehouse , Vice President and CCO Charles K Gayer , and Exec Director & Finance - PAO Michael L Jones .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, George B Abercrombie made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
George B Abercrombie Mailing Address
Above is the net worth, insider trading, and ownership report for George B Abercrombie. You might contact George B Abercrombie via mailing address: C/o Inspire Pharmaceuticals, Inc., 4222 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
